NEUROFIBRILLARY PATHOLOGY IN PROGRESSIVE SUPRANUCLEAR PALSY (PSP)

被引:0
|
作者
CERVOSNAVARRO, J
SCHUMACHER, K
机构
关键词
D O I
暂无
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
In progressive supranuclear palsy (PSP), globose neurofibrillary tangles (NFT) are found in the subcortical areas and occasionally in the central cortex and spinal cord. An inverse relationship was found between the degree of neuronal loss and the presence of NFT. It has been postulated that NFT comes first and atrophy as a secondary event. Others authors have reported that the neurologic findings are associated with the presence of carcinomas and the CNS changes can be assessed as a paraneoplastic effect. In PSP the neuritic changes are mainly located in the basal ganglia and composed of straight filaments and tubules, different from the paired helical filaments found in the Alzheimer's disease, suggesting that they are formed of a new type of fibrous protein. In addition immunohistochemistry preparations using antibodies against tau and ubiquitin reveal an antigenic profile similar to early NFT in dementia of Alzheimer's type. These findings support the hypothesis that these changes may reflect different types of non-specific cytoskeletal disorganization.
引用
收藏
页码:153 / 164
页数:12
相关论文
共 50 条
  • [1] Clinical predictors of progressive supranuclear palsy (PSP) pathology in PSP syndrome
    Aiba, I.
    Saito, Y.
    Yokokawa, Y.
    Kenjo, M.
    Katayama, T.
    Hashimoto, R.
    Sakakibara, S.
    Inukai, A.
    Mimuro, M.
    Iwasaki, Y.
    Yoshida, M.
    MOVEMENT DISORDERS, 2016, 31 : S72 - S72
  • [2] PATHOLOGY OF THE DENTATE NUCLEUS IN PROGRESSIVE SUPRANUCLEAR PALSY (PSP)
    MIZUSAWA, H
    HIRANO, A
    LLENA, JF
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1988, 47 (03): : 337 - 337
  • [3] SIGNIFICANCE OF ULTRASTRUCTURALLY DIFFERENT NEUROFIBRILLARY TANGLES (NFT) IN PROGRESSIVE SUPRANUCLEAR PALSY (PSP)
    NELSON, RF
    KAPOOR, A
    MONTPETIT, V
    GUBERMAN, A
    CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1984, 11 (02) : 350 - 350
  • [4] Progressive supranuclear palsy (PSP)
    Schwarz, J.
    Arnold, G.
    Csoti, I.
    Fogel, W.
    Oechsners, M.
    Urban, P.
    Walter, U.
    Storch, A.
    AKTUELLE NEUROLOGIE, 2007, 34 : S25 - S27
  • [5] Pramipexole in progressive supranuclear palsy (PSP)
    Weiner, WJ
    Minagar, A
    Shulman, LM
    NEUROLOGY, 1998, 50 (04) : A386 - A386
  • [6] Olfaction in progressive supranuclear palsy (PSP)
    Silveira-Moriyama, L.
    Hughes, G.
    Church, A.
    Ayling, H.
    Williams, D. R.
    Petrie, A.
    Holton, J.
    Revesz, T.
    Kingsbury, A.
    Morris, H. R.
    Burn, D. J.
    Lees, A. J.
    MOVEMENT DISORDERS, 2009, 24 : S420 - S421
  • [7] Increase of cdk5 is related to neurofibrillary pathology in progressive supranuclear palsy
    Borghi, R
    Giliberto, L
    Assini, A
    Delacourte, A
    Perry, G
    Smith, MA
    Strocchi, P
    Zaccheo, D
    Tabaton, M
    NEUROLOGY, 2002, 58 (04) : 589 - 592
  • [8] A comparison between progressive supranuclear palsy (PSP) and corticobasal degeneration on the cytoskeletal pathology
    Abe, H
    Yagishita, S
    Inoue, M
    Amano, N
    BRAIN PATHOLOGY, 1997, 7 (04) : 1331 - 1331
  • [9] Hippocampal pathology in progressive supranuclear palsy (PSP): a quantitative study of 8 cases
    Armstrong, R. A.
    Lantos, P. L.
    Cairns, N. J.
    CLINICAL NEUROPATHOLOGY, 2009, 28 (01) : 46 - 53
  • [10] ULTRASTRUCTURE OF NEUROFIBRILLARY TANGLES IN PROGRESSIVE SUPRANUCLEAR PALSY
    TOMONAGA, M
    ACTA NEUROPATHOLOGICA, 1977, 37 (02) : 177 - 181